Sclerostin binding agents

Details for Australian Patent Application No. 2012238247 (hide)

Owner Amgen, Inc. UCB Pharma S.A.

Inventors Winters, Aaron George; Lawson, Alastair; Henry, Alistair James; Popplewell, Andy; Paszty, Christopher; Shen, Wenyan; Lu, Hsieng Sen; Latham, John; Hoffmann, Kelly Sue; Graham, Kevin; Robinson, Martyn Kim; Winkler, David

Agent Davies Collison Cave

Pub. Number AU-A-2012238247

Parent 2006242431

Filing date 8 October 2012

Wipo publication date 1 November 2012

International Classifications

C07K 14/51 Peptides having more than 20 amino acids

C07K 16/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

25 October 2012 Complete Application Filed

1 November 2012 Application Open to Public Inspection

  Published as AU-A-2012238247

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012238248-Apparatus and method for delivering a fluid

2012238246-Light emitting diode load protection circuit